Clinical Trials Logo

Clinical Trial Summary

Low back pain (LBP) is the largest cause of morbidity in the world, and about 80% of Chinese people are affected in their lifetime. Although the prevalence of IDD gradually increases with age, IDD is very common among subjects under 30 years old. In addition to age, there are other factors, such as excessive or uneven mechanical load, obesity, genetics, nutrition, trauma and gender. In addition, it is not clear whether the heavy physical load associated with occupation is an important risk factor for IDD. Some studies have found that IDD is more common among athletes than the general population. Due to the complexity and multifactorial nature of IDD, its pathogenesis and risk factors are still unclear, which seriously hinders the rational stratification of LBP patients and limits the development of personalized treatment.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05976516
Study type Observational
Source Zhongda Hospital
Contact
Status Recruiting
Phase
Start date August 1, 2023
Completion date March 30, 2024

See also
  Status Clinical Trial Phase
Completed NCT01496898 - Changes in Vaginal, Cervical and Uterine Microflora With Levonorgestrel Intrauterine Device Placement N/A
Recruiting NCT03825471 - Cranial Electrotherapy Stimulation on Anesthetics Consumption and Postoperative Pain N/A
Not yet recruiting NCT06199947 - Study of the Role of Oncostatin M in Head and Neck Squamous Cell Carcinoma N/A